bupropion
- Product NDC
- 70934-151
- 11-digit product format
- 709340151
- Labeler code
- 70934
- Product ID
- 70934-151_d22cea74-2994-7165-e053-2a95a90a76b3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA202304
- Marketing category
- ANDA
- Marketing start
- 2019-05-13
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-151-30 | 70934015130 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-151-30) | 2019-09-26 | 0000-00-00 | No | No | Current |
| 70934-151-60 | 70934015160 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-151-60) | 2020-06-16 | 0000-00-00 | No | No | Current |
| 70934-151-90 | 70934015190 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-151-90) | 2020-05-14 | 0000-00-00 | No | No | Current |
| 70934-151-96 | 70934015196 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-151-96) | 2019-05-13 | 0000-00-00 | No | No | Current |